List of works - Elaine Peskind

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

scientific article (publication date: August 1996)

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

scientific article

The ageing systemic milieu negatively regulates neurogenesis and cognitive function.

scientific article

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers

scientific article

Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans

scientific article

The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery

scientific article

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group

scientific article published in June 2000

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

scientific article

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype

scientific article published in January 1998

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

scientific article

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

scientific article

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

scientific article

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series

scientific article

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

scientific article

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease

scientific article

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

scientific article published on 14 August 2007

Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease

scientific article published on August 2008

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

scientific article published in December 2003

A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

scientific article published on 25 October 2006

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics

scientific article published in May 1994

Testosterone supplementation improves spatial and verbal memory in healthy older men.

scientific article published in July 2001

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

scientific article

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

scientific article published on July 2012

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

scientific article published on April 2008

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 28 February 2019

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial

scientific article published in August 2006

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

scientific article published in August 2006

Changes in the sleep and waking EEGs of nondemented and demented elderly subjects

scientific article published in February 1982

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial

scientific article published in November 2000

Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type

scientific article published in January 1982

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study

scientific article published in November 2004

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

scientific article

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

scientific article

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

scientific article

Insulin increases CSF Abeta42 levels in normal older adults

scientific article

A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

scientific article

The role of aromatization in testosterone supplementation: effects on cognition in older men.

scientific article published in January 2005

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association

scientific article

Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study

scientific article

Phosphorylated α-synuclein in Parkinson's disease

scientific article

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.

scientific article

Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms.

scientific article published on 10 April 2010

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

scientific article

Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance

scientific article published on 01 July 1996

Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults

scientific article

Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.

scientific article

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)

scientific article published in April 1999

Safety and acceptability of the research lumbar puncture

scientific article published in October 2005

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

scientific article (publication date: 12 January 2011)

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition

scientific article published in July 2006

List of works by Elaine Peskind

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

The ageing systemic milieu negatively regulates neurogenesis and cognitive function.

The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers

Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans

The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series

YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease

GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics

Testosterone supplementation improves spatial and verbal memory in healthy older men.

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.

Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Changes in the sleep and waking EEGs of nondemented and demented elderly subjects

Treatment of agitation in AD: a randomized, placebo-controlled clinical trial

Sleep, EEG and mental function changes in senile dementia of the Alzheimer's type

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment

Insulin increases CSF Abeta42 levels in normal older adults

A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

The role of aromatization in testosterone supplementation: effects on cognition in older men.

Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association

Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study

Phosphorylated α-synuclein in Parkinson's disease

Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.

Cerebrocerebellar hypometabolism associated with repetitive blast exposure mild traumatic brain injury in 12 Iraq war Veterans with persistent post-concussive symptoms.

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance

Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults

Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)

Safety and acceptability of the research lumbar puncture

Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition